Janus Henderson Investors US’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Janus Henderson Investors US's PFE Position: Q1 2017 in Review
Janus Henderson Investors US reduced its Pfizer (PFE) stake by 23% in Q1 2017, selling an estimated $107M and leaving 11,555,466 shares worth $375M. The position accounts for 0.31% of the portfolio, ranked #84.
Janus Henderson Investors US first reported a position in PFE in Q2 2013 and has held it in 16 quarters since. The position peaked at $523M in Q3 2016. 2,075 funds tracked by Wall St. Rank hold PFE as of Q1 2017.
- Janus Henderson Investors US held 11,555,466 shares of Pfizer worth $375M as of Q1 2017.
- Janus Henderson Investors US sold 3,407,896 Pfizer shares in Q1 2017, an estimated $107M.
- Pfizer made up 0.31% of Janus Henderson Investors US's portfolio in Q1 2017, its #84 holding.
- Janus Henderson Investors US first reported a position in Pfizer in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's Pfizer position peaked at $523M in Q3 2016.
- 2,075 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.